Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

International Stem Cell (ISCO) Operating Income (2016 - 2025)

Historic Operating Income for International Stem Cell (ISCO) over the last 17 years, with Q3 2025 value amounting to $94000.0.

  • International Stem Cell's Operating Income rose 20444.44% to $94000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $97000.0, marking a year-over-year increase of 11786.37%. This contributed to the annual value of -$68000.0 for FY2024, which is 8974.36% up from last year.
  • International Stem Cell's Operating Income amounted to $94000.0 in Q3 2025, which was up 20444.44% from $167000.0 recorded in Q2 2025.
  • In the past 5 years, International Stem Cell's Operating Income ranged from a high of $167000.0 in Q2 2025 and a low of -$623000.0 during Q3 2021
  • For the 5-year period, International Stem Cell's Operating Income averaged around -$146684.2, with its median value being -$97000.0 (2023).
  • In the last 5 years, International Stem Cell's Operating Income crashed by 900000.0% in 2024 and then surged by 20444.44% in 2025.
  • Quarter analysis of 5 years shows International Stem Cell's Operating Income stood at -$323000.0 in 2021, then skyrocketed by 118.89% to $61000.0 in 2022, then plummeted by 795.08% to -$424000.0 in 2023, then surged by 112.03% to $51000.0 in 2024, then surged by 84.31% to $94000.0 in 2025.
  • Its last three reported values are $94000.0 in Q3 2025, $167000.0 for Q2 2025, and -$215000.0 during Q1 2025.